ASCO

When Good Cells Go Bad: The Stem Cell Origin of Cancers

March 16, 2007
David Jablons

DAVID JABLONS, University of California, San Francisco

REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain
Cell signalling using the Wnt pathway may hold the key to many, if not all, the genetic pathways to cancer, according to David Jablons, who delivered the Keynote Lecture during the Lung Cancer conference in Seville. After his talk he discussed his latest scientific findings with Peter Goodwin.

To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.

Add podcast to iTunes

Similar Interviews

  • Audio Journal of Oncology in Advance – April 1st, 2007 – reporting From: Journal of Clinical Oncology, January 20th, 2007 & December 20, 2006

    • George Canellos Robert Motzer Hormone Replacement Therapy: Better Survival With Colorectal Cancer REFERENCE: J Clin Oncol 24:5680-5686

  • Audio Journal of Oncology in Advance – April 15th, 2007 – Bisphosphonates Recommended for Lung Cancer Bone Metastases

    • PETER HARPER, Guy’s Hospital, London REFERENCE: “Management of Tumour and Treatment Related Symptoms” section, Perspectives in Lung Cancer, Seville Bisphosphonates may be

  • Audio Journal of Oncology in Advance – January 15th, 2007 – HERA Study Results Confirm Trastuzumab Benefit in HER2 Positive Early Breast Cancer

    • IAN SMITH, Royal Marsden Hospital, London REFERENCE: Lancet 369:29 Confirmation of the life-extending benefits of trastuzumab adjuvant therapy for early breast

    Post a comment